Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma

NCT01534078

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma

NCT02247869

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • UO Ematologia Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Dipartimento di Oncologia Medica ed Ematologia Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Oncologia HSR Giglio Cefalù, Palermo, Italy
  • Oncologia Medica A Centro di Riferimento Oncologico Aviano, Pordenone, Italy
View all 37 locations
View Trial Details
Completed

BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV

NCT02244021

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations
  • Istituto di Ematologia "L. & A. Seragnoli" , Policlinico S. Orsola Malpighi Bologna, Italy
  • Ematologia, IRCCS AOU San Martino-IST Genova, Italy
  • Ematologia Ospedale Vito Fazzi Lecce, Italy
  • Ematologia e Unità BMT IRCCS Istituto Nazionale dei Tumori Milan, Italy
View Trial Details
Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

NCT00784537

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Centro di riferimento Oncologico Oncologia Medica A Aviano, Italy
  • Università Policlinico di Bari - Divisione di Medicina A Bari, Italy
  • Policlinco Sant'Orsola Isituto di Ematologia ed oncologia Medica Bologna, Italy
  • Sezione di Ematologia Spedali Civili Brescia, Italy
View all 27 locations
View Trial Details
Completed

Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT00068250

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Integrated Community Oncology Network at Southside Cancer Center Jacksonville, Florida, United States
  • Baptist Medical Center South Jacksonville, Florida, United States
  • Integrated Community Oncology Network Jacksonville Beach, Florida, United States
View all 26 locations
View Trial Details

Related conditions